Taken once weekly, Tirzepatide is the first therapy of its kind to target GLP-1 and GIPtwo key players in controlling blood sugar, appetite, and digestion
March 19, 2026 4:28 View More When Thyroid Care Finally Starts Listening - Why Personalized Treatment Changes Everything with Yari Tran Melody Volz and Nikki Abelow What if thyroid patients struggle not because of the condition itself, but because of how thyroid care is traditionally approached
Below are some considerations to take as part of your weight loss plan
Early findings are promising
Cell arrangement Described using the format xSyP (where x and y are integers), this tells you how the cells in the battery are wired up
Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry GLP-1 Receptor Agonists up Risk of Gallbladder and Biliary Disease Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended for patients with type 2 diabetes to control glycemia and reduce cardiovascular risk and for patients with obesity to reduce weight
